The estimated Net Worth of Nicole S White is at least $244 Mille dollars as of 2 August 2024. Nicole White owns over 785 units of Assembly Biosciences Inc stock worth over $209,742 and over the last few years he sold ASMB stock worth over $34,106. In addition, he makes $0 as Senior Vice President - Pharmaceutical Development and Manufacturing at Assembly Biosciences Inc.
Nicole has made over 6 trades of the Assembly Biosciences Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently he sold 785 units of ASMB stock worth $11,171 on 2 August 2024.
The largest trade he's ever made was selling 1,891 units of Assembly Biosciences Inc stock on 2 October 2023 worth over $1,513. On average, Nicole trades about 796 units every 51 days since 2023. As of 2 August 2024 he still owns at least 12,068 units of Assembly Biosciences Inc stock.
You can see the complete history of Nicole White stock trades at the bottom of the page.
Dr. Nicole S. White Ph.D. serves as Senior Vice President - Pharmaceutical Development and Manufacturing of the Company. Prior to joining Assembly Bio, Dr. White headed Process Chemistry at Gossamer Bio and led chemistry, manufacturing and controls (CMC) for multiple early- and late-stage programs in development. Prior to that she held progressive leadership roles at Gilead Sciences to advance multiple programs from Phase 1 through commercial launch and helped guide the drug substance manufacturing and global outsourcing strategy. While at Gilead, Dr. White contributed to the development and commercial launch of multiple antiviral programs including Harvoni ® , Vemlidy ® and Vosevi ® . She obtained a PhD in Organic Chemistry from the University of California, Irvine and a BS in Chemistry from the University of California, San Diego.
Nicole's mailing address filed with the SEC is C/O ASSEMBLY BIOSCIENCES, INC., TWO TOWER PLACE, 7TH FLOOR, SOUTH SAN FRANCISCO, CA, 94080.
Over the last 10 years, insiders at Assembly Biosciences Inc have traded over $1,523,622 worth of Assembly Biosciences Inc stock and bought 1,245,980 units worth $1,060,065 . The most active insiders traders include Sciences, Inc. Gilead, Myron Z Holubiak e Helen Susan Kim. On average, Assembly Biosciences Inc executives and independent directors trade stock every 46 days with the average trade being worth of $389,399. The most recent stock trade was executed by Nicole S White on 2 August 2024, trading 785 units of ASMB stock currently worth $11,171.
assembly biosciences, inc. (nasdaq: asmb) is a public clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis b virus (hbv) infection and novel oral live biotherapeutics for disorders associated with the microbiome. assembly is developing two innovative platform programs: an hbv program advancing a new class of oral therapeutics for the treatment of hepatitis b virus (hbv) infection and a microbiome program developing novel oral live biotherapeutics designed to address diseases associated with the microbiome. assembly’s hbv program is advancing multiple drug candidates with the aim of increasing cure rates in patients with chronic hbv. the company's microbiome program consists of a fully integrated platform that includes a robust strain identification and selection process, methods for strain isolation and growth under current good manufacturing practices and a patent-pending delivery system, gemicel®, which allows for targeted ora
Assembly Biosciences Inc executives and other stock owners filed with the SEC include: